IPEC e-newsletter - Excipients Insight August 2015 - 27-08-15


Inside this issue


Word of the Chair

Dear IPEC Europe members,

This edition comes to you at the end of what has on the whole been a nice and warm summer in Europe. We hope you all enjoyed pleasurable vacations, and wish those of you planning to extend the summer with a September break an enjoyable time.

During the summer IPEC Europe and our industry was of course not completely inactive, and this edition should help you catch up with some developments you may have missed in recent weeks.

Our 'new face' in the IPEC Europe office in Brussels, Ana Nechita, is introduced to you in this issue. We are delighted to welcome her on board, and are very happy to have some much-needed support for Carole Capitaine as we progress an ambitious and busy workload.

You can also read about activities of our sister association, IPEC Americas, and developments in the regulatory area, especially in the US and China. China is currently a hot topic, not only because of the economic situation and its impact on global economy. There are also some rumours about potential changes in the import licencing process for excipients in China. We will track this and keep you informed.

Furthermore, our IPEC Europe risk assessment team has started work, and is progressing with the development of guidance on the implementation of the excipient risk assessment according to the new EU guideline. Once again, we will keep you up to date with this important project in the coming months.

The next important event for IPEC Europe will be our annual conference together with APV in Barcelona on 23-24 September. There are still a few places available, and registration and other information can be found here.

Finally, please save the date for our next annual Excipient Forum and general meeting, which will be held next year on 4-5 February in Nice.

I hope to see you in Barcelona and/or Nice.

Kind regards,


Frank Milek

IPEC Europe Chair




Copyright © 2005 - 2018 IPEC Europe - International Pharmaceutical Excipients Council